Isopropyl palmitate, min. 90%, for synthesis, 2.5 l, plastic packaging.

4-Bromo-2,11-dihydrobenzo[2,3][1,4]oxazepino[5,6,7-cd]indazole, 95.0%, 250mg

Methyl 3-bromo-5-chloro-4-hydroxybenzoate, 97.74%, 100g

N-(4-FLUOROPHENYL)-4-PHENYL-1,3-THIAZOL-2-AMINE, 95%, 5mg

L-Threonine, 250 g

Variamine Blue B Sulfate (=4-Amino-4'-methoxydiphenylamine Sulfate) [for Iron-Titration]>97.0%(N)1g

2-Amino-5-formylthiazole, 95.0%, 25g

Methyl 2-Methoxyisonicotinate, 97.0%, 1g

(S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 95.0%, 250mg

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 1g

(-)-O-ACETYL-L-LACTIC ACID, 97.0%, 25g

Quinoline, 1,2,3,4-tetrahydro-2,6-dimethyl-, 98%, 1g

4-Bromo-2-methoxy-6-methylbenzonitrile, 97%, 1g